SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
224 hedge funds and large institutions have $2.54B invested in Sage Therapeutics in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 72 increasing their positions, 76 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.99% more ownership
Funds ownership: 88.53% → 90.53% (+2%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 76
Holders
224
Holding in Top 10
2
Calls
$21.6M
Puts
$16.6M
Top Buyers
| 1 | +$84.9M | |
| 2 | +$32.3M | |
| 3 | +$31.7M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$29.5M |
| 5 |
JP Morgan Chase
New York
|
+$15.8M |
Top Sellers
| 1 | -$41.2M | |
| 2 | -$30.5M | |
| 3 | -$25.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$21.7M |
| 5 |
Goldman Sachs
New York
|
-$21.6M |